Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Robert Gourdie
Virginia Polytechnic Inst and St Univ, Department: Miscellaneous
Should you be removed from our database? Contact us at [email protected]. Read more below.
FirstString Research, Inc.
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
Dr. Robert Gourdie is the PI of a National Heart, Lung and Blood Institute project titled Gap Junctional Patterning in the Arrhythmic Heart. Dr. Gourdie indicated in year 4 that he has a significant financial interest in the peptide being used in this project. This peptide was invented by Dr. Gourdie at the Medical University of South Carolina. A non-publicly traded entity FirstString Research, Inc. was created based upon the development of this peptide. FirstString Research, Inc. has an exclusive license for the use and any application of the peptide through MUSC. This peptide is a significant part of the sponsored project. Dr. Gourdie and (b)(6) have an equity interest in FirstString Research, Inc. and receive periodic ownership royalties from MUSC as inventors of record.
Funding
Gap Junctional Patterning in the Arrhythmic Heart
Ischemic heart disease is a leading cause of death in the USA and many of the deaths from this disease result from arrhythmias caused by muscle loss that occurs following a myocardial infarct. This loss of heart muscle can be made worse by clinical interventions such as angioplasty that restore blood flow following myocardial infarction. In this project we will explore the function and potential pharmacology of an important new therapeutic target in myocardial infarct, reperfusion injury and arrhythmia - the Cx43 hemichannel.
Filed on February 26, 2019.
Tell us what you know about Robert Gourdie's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.